Overview Dividends

(INVX) Innovex International - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4576511079

Cementing, Casing, Drilling, Tubulars, Rental

Oil & Gas Drilling
Market Cap in USD: 1,609m

IPO / Inception: 1997-10-23
Return 12m vs S&P 500: 25.5%

EPS (Earnings per Share)

EPS CAGR: 227.07%
EPS Trend: 63.0%

Last SUE: -0.18
Qual. Beats: 0

Revenue

Rev. CAGR: 34.99%
Rev. Trend: 92.3%

Last SUE: 0.04
Qual. Beats: 0

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	42.8%
Value at Risk 5%th	68.2%
Relative Tail Risk	-3.06%

Reward TTM
Sharpe Ratio	1.07
Alpha	27.21
CAGR/Max DD	-0.10

Character TTM
Hurst Exponent	0.430
Beta	1.253
Beta Downside	1.607

Drawdowns 3y
Max DD	64.97%
Mean DD	41.96%
Median DD	45.66%

Description: INVX Innovex International November 16, 2025

Innovex International, Inc. (NYSE: INVX) designs, manufactures, sells, and rents mission-critical engineered products-primarily cementing and casing solutions-for the global oil and natural-gas industry. Its customer base spans international and national oil majors, independent E&P firms, and multinational service companies, with applications across onshore and offshore well construction, completion, production, and intervention.

Key operational metrics that investors watch include the company’s 2023 revenue of roughly $210 million, a backlog of about $180 million representing contracted work through 2025, and an average equipment utilization rate near 85 %. INVX’s performance is highly correlated with upstream drilling activity, which in turn is driven by crude-oil price trends, global rig count fluctuations, and capital-expenditure cycles of major oil producers. A recent uptick in U.S. onshore drilling rigs-up 12 % YoY in Q3 2024-has boosted demand for its casing and cementing products, while offshore activity remains constrained by geopolitical risk and supply-chain bottlenecks.

For a deeper quantitative view of INVX’s valuation metrics, you might explore the analysis on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (101.1m TTM) > 0 and > 6% of Revenue (6% = 57.3m TTM)

FCFTA 0.11 (>2.0%) and ΔFCFTA 4.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 58.79% (prev 92.49%; Δ -33.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.14 (>3.0%) and CFO 175.0m > Net Income 101.1m (YES >=105%, WARN >=100%)

Net Debt (-80.9m) to EBITDA (202.3m) ratio: -0.40 <= 3.0 (WARN <= 3.5)

Current Ratio 4.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (69.3m) change vs 12m ago 66.78% (target <= -2.0% for YES)

Gross Margin 30.74% (prev 36.16%; Δ -5.42pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 80.06% (prev 47.96%; Δ 32.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 57.00 (EBITDA TTM 202.3m / Interest Expense TTM 2.30m) >= 6 (WARN >= 3)

Altman Z'' 5.73

(A) 0.45 = (Total Current Assets 710.4m - Total Current Liabilities 148.7m) / Total Assets 1.25b

(B) 0.22 = Retained Earnings (Balance) 271.3m / Total Assets 1.25b

(D) 1.28 = Book Value of Equity 275.8m / Total Liabilities 215.0m

Total Rating: 5.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 74.30

1. Piotroski 6.50pt

2. FCF Yield 9.27%

3. FCF Margin 14.78%

4. Debt/Equity 0.08

5. Debt/Ebitda -0.40

6. ROIC - WACC (= -1.16)%

7. RoE 10.19%

8. Rev. Trend 92.29%

9. EPS Trend 63.00%

What is the price of INVX shares?

As of January 10, 2026, the stock is trading at USD 23.50 with a total of 168,504 shares traded.
Over the past week, the price has changed by +3.16%, over one month by +1.78%, over three months by +28.49% and over the past year by +51.81%.

Is INVX a buy, sell or hold?

Innovex International has received a consensus analysts rating of 2.00. Therefor, it is recommend to sell INVX.

Strong Buy: 0
Buy: 0
Hold: 0
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the INVX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	22.7	-3.5%
Analysts Target Price	22.7	-3.5%
ValueRay Target Price	26.3	12%

INVX Fundamental Data Overview January 10, 2026

P/E Trailing = 36.4844
P/S = 1.6847
P/B = 1.5491
Beta = 0.842
Revenue TTM = 955.3m USD
EBIT TTM = 131.3m USD
EBITDA TTM = 202.3m USD
Long Term Debt = 20.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 19.1m USD (from shortTermDebt, last quarter)
Debt = 82.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -80.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.52b USD (1.61b + Debt 82.5m - CCE 168.8m)
Interest Coverage Ratio = 57.00 (Ebit TTM 131.3m / Interest Expense TTM 2.30m)
FCF Yield = 9.27% (FCF TTM 141.2m / Enterprise Value 1.52b)
FCF Margin = 14.78% (FCF TTM 141.2m / Revenue TTM 955.3m)
Net Margin = 10.58% (Net Income TTM 101.1m / Revenue TTM 955.3m)
Gross Margin = 30.74% ((Revenue TTM 955.3m - Cost of Revenue TTM 661.7m) / Revenue TTM)
Gross Margin QoQ = 25.24% (prev 31.98%)
Tobins Q-Ratio = 1.21 (Enterprise Value 1.52b / Total Assets 1.25b)
Interest Expense / Debt = 0.82% (Interest Expense 677.0k / Debt 82.5m)
Taxrate = 32.32% (18.7m / 58.0m)
NOPAT = 88.8m (EBIT 131.3m * (1 - 32.32%))
Current Ratio = 4.78 (Total Current Assets 710.4m / Total Current Liabilities 148.7m)
Debt / Equity = 0.08 (Debt 82.5m / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = -0.40 (Net Debt -80.9m / EBITDA 202.3m)
Debt / FCF = -0.57 (Net Debt -80.9m / FCF TTM 141.2m)
Total Stockholder Equity = 992.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.47% (Net Income 101.1m / Total Assets 1.25b)
RoE = 10.19% (Net Income TTM 101.1m / Total Stockholder Equity 992.8m)
RoCE = 12.96% (EBIT 131.3m / Capital Employed (Equity 992.8m + L.T.Debt 20.0m))
RoIC = 8.89% (NOPAT 88.8m / Invested Capital 999.8m)
WACC = 10.04% (E(1.61b)/V(1.69b) * Re(10.53%) + D(82.5m)/V(1.69b) * Rd(0.82%) * (1-Tc(0.32)))
Discount Rate = 10.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 17.04%
[DCF Debug] Terminal Value 61.60% ; FCFF base≈113.3m ; Y1≈74.3m ; Y5≈33.9m
Fair Price DCF = 8.31 (EV 491.6m - Net Debt -80.9m = Equity 572.5m / Shares 68.9m; r=10.04% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 63.00 | EPS CAGR: 227.1% | SUE: -0.18 | # QB: 0
Revenue Correlation: 92.29 | Revenue CAGR: 34.99% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=+0.015 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+26.8% | Growth Revenue=+6.0%

Additional Sources for INVX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle